Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atrium Therapeutics, Inc. | 43,601 | reported | 20 Apr 2026 | tx 2+90,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Apr 2026 | GRANT_AWARD | Atrium Therapeutics, Inc. | 30,000 | 0.00 USD | |
| 20 Apr 2026 | GRANT_AWARD | Atrium Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |